Procházka, V., Gazdová, J., & Papajík, T. (2012). Fc gamma receptor 3a genotype in follicular lymphoma: The end of the story? Reply to “Fc gamma receptor 3a genotype predicts overall survival in follicular lymphoma patients treated on SWOG trials with combined monoclonal antibody plus chemotherapy but not chemotherapy alone”. Haematologica. 2012;97(6):937-942. Ferrata Storti Foundation.
Chicago Style aipamenaProcházka, Vít, Jana Gazdová, and Tomáš Papajík. Fc Gamma Receptor 3a Genotype in Follicular Lymphoma: The End of the Story? Reply to “Fc Gamma Receptor 3a Genotype Predicts Overall Survival in Follicular Lymphoma Patients Treated On SWOG Trials With Combined Monoclonal Antibody Plus Chemotherapy but Not Chemotherapy Alone”. Haematologica. 2012;97(6):937-942. Ferrata Storti Foundation, 2012.
MLA aipamenaProcházka, Vít, Jana Gazdová, and Tomáš Papajík. Fc Gamma Receptor 3a Genotype in Follicular Lymphoma: The End of the Story? Reply to “Fc Gamma Receptor 3a Genotype Predicts Overall Survival in Follicular Lymphoma Patients Treated On SWOG Trials With Combined Monoclonal Antibody Plus Chemotherapy but Not Chemotherapy Alone”. Haematologica. 2012;97(6):937-942. Ferrata Storti Foundation, 2012.